Market Cap 152.52B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.59
Forward PE 8.81
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 49,786,700
Avg Vol 44,586,855
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 95%
Beta 0.34
Analysts Sell
Price Target $28.60

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
PixelMarkets
PixelMarkets Aug. 11 at 5:54 AM
$CRWD $DOGE $SLN $DRAM $PFE CrowdStrike benefits from persistent cybersecurity spending, Dogecoin remains highly sentiment-driven, SLN remains speculative, DRAM demand benefits from AI infrastructure, and Pfizer continues advancing its pharmaceutical pipeline. I'm watching security budgets, crypto liquidity, memory pricing, and clinical catalysts.
0 · Reply
ProtocolPartners
ProtocolPartners Aug. 11 at 4:29 AM
$ANTHZZX $SRPT $PFE $APP $OSS ANTHZZX remains highly speculative, Sarepta advances genetic medicines, Pfizer continues developing its pharmaceutical pipeline, AppLovin benefits from AI-enhanced advertising, and OSS remains execution-dependent. I'm watching liquidity, clinical milestones, ad growth, and company-specific catalysts.
0 · Reply
NodeSecurities
NodeSecurities Aug. 11 at 4:08 AM
$CRWD $DOGE $SLN $DRAM $PFE CrowdStrike benefits from persistent cybersecurity spending, Dogecoin remains highly sentiment-driven, SLN remains speculative, DRAM demand benefits from AI infrastructure, and Pfizer continues advancing its pharmaceutical pipeline. I'm watching security budgets, crypto liquidity, memory pricing, and clinical catalysts.
0 · Reply
ObsidianAdvisors
ObsidianAdvisors Aug. 11 at 3:36 AM
$CRWD $DOGE $SLN $DRAM $PFE CrowdStrike benefits from persistent cybersecurity spending, Dogecoin remains highly sentiment-driven, SLN remains speculative, DRAM demand benefits from AI infrastructure, and Pfizer continues advancing its pharmaceutical pipeline. I'm watching security budgets, crypto liquidity, memory pricing, and clinical catalysts.
0 · Reply
jrh34
jrh34 Aug. 11 at 3:04 AM
$PFE $30 print coming.
0 · Reply
neversurrender2024
neversurrender2024 Aug. 11 at 1:47 AM
$PFE no mrna vaccines for me! https://x.com/FiveTimesAugust/status/2082491516140855547
1 · Reply
Spicy_Trade
Spicy_Trade Aug. 11 at 1:23 AM
Pfizer, Inc. ( $PFE ) SpicyTrade - Daily Stock Analysis https://youtu.be/SiTNWGfwS7k?si=7VSg6tX4P8J2tYv8
0 · Reply
EmbraceVolatility
EmbraceVolatility Aug. 11 at 1:13 AM
$PFE Again, defies logic.
0 · Reply
LuisBarajas16
LuisBarajas16 Aug. 11 at 12:50 AM
$INO question for those who where here since Covid or understand legal proceedings. Knowing the case that is going on with Dr. Fraudci- they knew how back the safety and efficacy were on the vaccines that were rolled out. Despite knowing this they allowed for mass distribution and enforcement. Politicians pocketed money since they were invested heavily in $MRNA $PFE . So their interest for these companies to succeed was at stake. …..CONFLICT OF INTEREST……. Can one start a class action against them? Knowing that we were one of the forefront companies? With a safer and effective vaccine?
3 · Reply
GordoHLYK13
GordoHLYK13 Aug. 11 at 12:19 AM
$IGC IGC is lining up for a major catalyst: CALMA has hit its full 146-patient enrollment target and is advancing toward topline analysis. Add its AI platform, Alzheimer’s-focused pipeline, and growing investor attention—and the setup is getting VERY interesting. 🚀🧠 $IGC $PFE $MRNA
0 · Reply
Latest News on PFE
Pfizer price target lowered to $31 from $35 at Guggenheim

2026-08-07T11:40:49.000Z - 3 days ago

Pfizer price target lowered to $31 from $35 at Guggenheim


Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-06T13:09:00.000Z - 4 days ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View


Pfizer price target raised to $27 from $26 at BofA

2026-08-05T10:45:23.000Z - 5 days ago

Pfizer price target raised to $27 from $26 at BofA


Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 6 days ago

Pfizer Earnings Call Transcript: Q2 2026


Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 6 days ago

Pfizer Earnings release: Q2 2026


Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 6 days ago

Pfizer Slides: Q2 2026


Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 6 days ago

Pfizer Quarterly report: Q2 2026


Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 6 days ago

Pfizer Post Loss on Higher Revenue


Pfizer reports Q2 adjusted EPS 77c, consensus 68c

2026-08-04T10:52:17.000Z - 6 days ago

Pfizer reports Q2 adjusted EPS 77c, consensus 68c


Pfizer says LITFULO studies meet co-primary endpoints

2026-07-30T11:03:18.000Z - 11 days ago

Pfizer says LITFULO studies meet co-primary endpoints


Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 5 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 6 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 6 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 7 weeks ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer Announces Chief Financial Officer Transition


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update


Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026


PixelMarkets
PixelMarkets Aug. 11 at 5:54 AM
$CRWD $DOGE $SLN $DRAM $PFE CrowdStrike benefits from persistent cybersecurity spending, Dogecoin remains highly sentiment-driven, SLN remains speculative, DRAM demand benefits from AI infrastructure, and Pfizer continues advancing its pharmaceutical pipeline. I'm watching security budgets, crypto liquidity, memory pricing, and clinical catalysts.
0 · Reply
ProtocolPartners
ProtocolPartners Aug. 11 at 4:29 AM
$ANTHZZX $SRPT $PFE $APP $OSS ANTHZZX remains highly speculative, Sarepta advances genetic medicines, Pfizer continues developing its pharmaceutical pipeline, AppLovin benefits from AI-enhanced advertising, and OSS remains execution-dependent. I'm watching liquidity, clinical milestones, ad growth, and company-specific catalysts.
0 · Reply
NodeSecurities
NodeSecurities Aug. 11 at 4:08 AM
$CRWD $DOGE $SLN $DRAM $PFE CrowdStrike benefits from persistent cybersecurity spending, Dogecoin remains highly sentiment-driven, SLN remains speculative, DRAM demand benefits from AI infrastructure, and Pfizer continues advancing its pharmaceutical pipeline. I'm watching security budgets, crypto liquidity, memory pricing, and clinical catalysts.
0 · Reply
ObsidianAdvisors
ObsidianAdvisors Aug. 11 at 3:36 AM
$CRWD $DOGE $SLN $DRAM $PFE CrowdStrike benefits from persistent cybersecurity spending, Dogecoin remains highly sentiment-driven, SLN remains speculative, DRAM demand benefits from AI infrastructure, and Pfizer continues advancing its pharmaceutical pipeline. I'm watching security budgets, crypto liquidity, memory pricing, and clinical catalysts.
0 · Reply
jrh34
jrh34 Aug. 11 at 3:04 AM
$PFE $30 print coming.
0 · Reply
neversurrender2024
neversurrender2024 Aug. 11 at 1:47 AM
$PFE no mrna vaccines for me! https://x.com/FiveTimesAugust/status/2082491516140855547
1 · Reply
Spicy_Trade
Spicy_Trade Aug. 11 at 1:23 AM
Pfizer, Inc. ( $PFE ) SpicyTrade - Daily Stock Analysis https://youtu.be/SiTNWGfwS7k?si=7VSg6tX4P8J2tYv8
0 · Reply
EmbraceVolatility
EmbraceVolatility Aug. 11 at 1:13 AM
$PFE Again, defies logic.
0 · Reply
LuisBarajas16
LuisBarajas16 Aug. 11 at 12:50 AM
$INO question for those who where here since Covid or understand legal proceedings. Knowing the case that is going on with Dr. Fraudci- they knew how back the safety and efficacy were on the vaccines that were rolled out. Despite knowing this they allowed for mass distribution and enforcement. Politicians pocketed money since they were invested heavily in $MRNA $PFE . So their interest for these companies to succeed was at stake. …..CONFLICT OF INTEREST……. Can one start a class action against them? Knowing that we were one of the forefront companies? With a safer and effective vaccine?
3 · Reply
GordoHLYK13
GordoHLYK13 Aug. 11 at 12:19 AM
$IGC IGC is lining up for a major catalyst: CALMA has hit its full 146-patient enrollment target and is advancing toward topline analysis. Add its AI platform, Alzheimer’s-focused pipeline, and growing investor attention—and the setup is getting VERY interesting. 🚀🧠 $IGC $PFE $MRNA
0 · Reply
taxplanr
taxplanr Aug. 11 at 12:17 AM
$BNTX $MRNA $PFE Germany geeting it done https://childrenshealthdefense.org/defender/german-court-rules-biontech-release-covid-vaccine-injury-records/?utm_source=cc&utm_medium=email&utm_campaign=defender&utm_id=20260810
0 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 10 at 11:03 PM
$PFE dont spook it
2 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 10 at 11:03 PM
$PFE shhhh
0 · Reply
Wallst45
Wallst45 Aug. 10 at 11:02 PM
$PFE why are we even going up !
1 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 10 at 10:52 PM
$PFE i just knew when i saw another quarter, that they were gona take that one...
0 · Reply
LoneBroker
LoneBroker Aug. 10 at 9:02 PM
0 · Reply
EmbraceVolatility
EmbraceVolatility Aug. 10 at 8:34 PM
$PFE Minor headwinds. Should see $27.75 soon. Then the decision to sell or short.
0 · Reply
JBS_84
JBS_84 Aug. 10 at 8:19 PM
$PFE For anyone interested my CC's are for Aug 21 at 26.5. -200. If they get assigned whatever I'm ok either way. A pullback will happen eventually here though.
1 · Reply
TheUnmaker
TheUnmaker Aug. 10 at 8:18 PM
$TNXP Today confirmed the setup with massive over than average volume. Algos re ready to run higher. We will break $14.15 this week and then looking for demand over $16. $PFE $JNJ $GRAL $SLS
1 · Reply
goguryo2000
goguryo2000 Aug. 10 at 8:12 PM
$PFE still not 30 yet... too slow... but hoping this can break 28 soon, seems doable in very near future
0 · Reply
TheWinningStock
TheWinningStock Aug. 10 at 8:11 PM
$SION <<---high risk high return $PFE $IOVA <<<---winners ...
0 · Reply
stockjusthave
stockjusthave Aug. 10 at 7:36 PM
$PFE when
0 · Reply